Skip to main content
main-content

Hypertension

Latest articles

13-02-2017 | Hypertension | News | Article

Quarter-dose quadpill a promising antihypertensive approach

A pilot randomized crossover trial suggests that giving patients a single pill composed of four antihypertensives at a quarter of their usual dose is a promising means of controlling blood pressure.

Source:

Lancet 2017; Advance online publication

11-01-2017 | Hypertension | News | Article

Editor's pick

Global increase in elevated systolic blood pressure and associated deaths

The number of people with elevated systolic blood pressure and the number of associated deaths have “increased substantially” in the past 25 years, results from the Global Burden of Disease, Injuries, and Risk Factors 2015 study suggest.

Source:

JAMA 2017; 317: 142–143, 165–182

13-12-2016 | Hypertension | News | Article

News in brief

Clinic blood pressure underestimates ambulatory blood pressure

Researchers report that ambulatory blood pressure is higher than clinic BP in healthy employed people, in contrast to “a widely held belief.”

18-11-2016 | Hypertension | News | Article

Substantial burden of high blood pressure in low- and middle-income countries

The number of people living with high blood pressure has almost doubled worldwide over the past 4 decades, with the biggest rise in low- and middle-income countries, according to an analysis of data from 19.1 million people.

Source:

Lancet 2016; Advance online publication

07-09-2016 | Coronary heart disease | News | Article

Cautious antihypertensive approach advised for CHD patients

Analysis of the CLARIFY registry shows a J-shaped curve between blood pressure and cardiovascular outcomes in patients with established coronary heart disease.

Source:

Lancet 2016; Advance online publication

06-09-2016 | Coronary heart disease | News | Article

Low DBP warns of cardiac damage in hypertensive patients

Research shows that low diastolic blood pressure is a marker of subclinical cardiac damage and increased coronary heart disease risk, particularly in patients with relatively high systolic blood pressure.

Source:

J Am Coll Cardiol 2016; Advance online publication

17-08-2016 | Hypertension | News | Article

BP variability increases CVD risk over and above the mean

Long-term variability in blood pressure, measured in the clinic, is associated with an increased risk of cardiovascular disease events and mortality, regardless of mean blood pressure, results of a systematic review and meta-analysis show.

Source:

BMJ 2016; 354: i4098

09-08-2016 | Hypertension | News | Article

Disparities in global hypertension rates widening

Nearly one-third of the world’s adult population had hypertension in 2010, with prevalence higher in low- and middle-income countries than in high-income countries for the first time in history, researchers report.

Source:

Circulation 2016; 134: 441–450

05-08-2016 | Hypertension | News | Article

Optimal BP range proposed for aortic stenosis patients

Analysis of the SEAS study participants pinpoints the blood pressure range that physicians should target for best outcomes in patients with asymptomatic aortic stenosis.

Source:

Circulation 2016; Advance online publication

18-07-2016 | Stroke | News | Article

Editor's pick

Expanded INTERSTROKE confirms global hypertension impact

Hypertension accounts for around half of all strokes in all regions of the world, show the results of the second phase of INTERSTROKE.

Source:

Lancet 2016; Advance online publication

30-06-2016 | Hypertension | News | Article

BP effects on vasculature begin below hypertensive threshold

Higher systolic blood pressure is associated with increased carotid intima-media thickness even within the normotensive range, research shows.

Source:

J Am Heart Assoc 2016; 5: e003529

28-06-2016 | Arrhythmia | News | Article

Pharmacotherapy reduces conduction system disease risk

Lisinopril therapy significantly reduces incident conduction system disease, indicates a post-hoc analysis of ALLHAT data.

Source:

JAMA Intern Med 2016; Advance online publication

13-06-2016 | Hypertension | News | Article

‘Hypertensive urgency’ may cause unnecessary alarm

Patients with a very high blood pressure reading in the absence of other symptoms are highly unlikely to have a major adverse cardiovascular event within the next 6 months, researchers report.

Source:

JAMA Intern Med 2016; Advance online publication

31-05-2016 | Hypertension | News | Article

Antihypertensive adherence may only partly explain BP variability

Study findings strengthen the suggestion that visit-to-visit variability in blood pressure is at least partly accounted for by patients’ adherence or otherwise to their antihypertensive medication.

Source:

Hypertension 2016; Advance online publication

24-05-2016 | Hypertension | News | Article

Urinary sodium excretion study attracts controversy

A pooled analysis in The Lancet showing a U-shaped association between urinary sodium excretion and cardiovascular disease has drawn criticism.

Source:

Lancet 2016; Advance online publication

20-05-2016 | Hypertension | News | Article

SPRINT supports stringent BP goals for elderly

Analysis of SPRINT participants older than 75 years shows that they too benefitted from an intensive blood pressure target of 120 mmHg.

Source:

JAMA 2016; Advance online publication

17-05-2016 | Hypertension | News | Article

Antihypertensive initiation, intensification linked to raised short-term fall risk

Older patients initiating or intensifying antihypertensive medication have a short-term increased risk of sustaining a serious fall injury, US study findings indicate.

Source:

Circ Cardiovasc Qual Outcomes 2016; Advance online publication

16-05-2016 | Hypertension | News | Article

High or rapidly rising BP poses greatest stroke, mortality risk

Findings from the Rotterdam study show how the trajectories of people’s blood pressure in mid to late life have varying effects on their risk of having a stroke or dying.

Source:

Hypertension 2016; Advance online publication

21-01-2016 | Endocrinology | News | Article

Parathyroid hormone may mediate antihypertensive fracture risk

medwireNews: Parathyroid hormone (PTH) levels may be elevated by use of some antihypertensive agents but reduced by others, analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) suggests. The ...

Source:

J Bone Miner Res 2016; Advance online publication

28-09-2014 | Cardiology | Article

Targeted treatments may improve idiopathic PAH survival

Patients with idiopathic pulmonary arterial hypertension may live longer if they are given targeted treatments than if they receive conventional management, researchers suggest.

Source:

Heart Lung 2014; Advance online publication

image credits